- Home
- RVYL vs GLMD Comparison
RVYL vs GLMD Comparison
Compare RVYL & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVYL
- GLMD
- Stock Information
- Founded
- RVYL 2007
- GLMD 2000
- Country
- RVYL United States
- GLMD Israel
- Employees
- RVYL N/A
- GLMD N/A
- Industry
- RVYL Professional Services
- GLMD Biotechnology: Pharmaceutical Preparations
- Sector
- RVYL Consumer Discretionary
- GLMD Health Care
- Exchange
- RVYL Nasdaq
- GLMD Nasdaq
- Market Cap
- RVYL 7.3M
- GLMD 6.6M
- IPO Year
- RVYL N/A
- GLMD 2014
- Fundamental
- Price
- RVYL $0.31
- GLMD $1.18
- Analyst Decision
- RVYL Hold
- GLMD Hold
- Analyst Count
- RVYL 1
- GLMD 1
- Target Price
- RVYL N/A
- GLMD N/A
- AVG Volume (30 Days)
- RVYL 9.6M
- GLMD 65.7K
- Earning Date
- RVYL 11-13-2025
- GLMD 11-14-2025
- Dividend Yield
- RVYL N/A
- GLMD N/A
- EPS Growth
- RVYL N/A
- GLMD N/A
- EPS
- RVYL N/A
- GLMD N/A
- Revenue
- RVYL $48,904,000.00
- GLMD N/A
- Revenue This Year
- RVYL N/A
- GLMD N/A
- Revenue Next Year
- RVYL $297.49
- GLMD N/A
- P/E Ratio
- RVYL N/A
- GLMD N/A
- Revenue Growth
- RVYL N/A
- GLMD N/A
- 52 Week Low
- RVYL $0.25
- GLMD $1.15
- 52 Week High
- RVYL $2.33
- GLMD $3.61
- Technical
- Relative Strength Index (RSI)
- RVYL 50.97
- GLMD 32.65
- Support Level
- RVYL $0.28
- GLMD $1.16
- Resistance Level
- RVYL $0.30
- GLMD $1.27
- Average True Range (ATR)
- RVYL 0.06
- GLMD 0.08
- MACD
- RVYL -0.00
- GLMD -0.02
- Stochastic Oscillator
- RVYL 21.29
- GLMD 0.00
About RVYL Ryvyl Inc.
Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.